189 related articles for article (PubMed ID: 16934317)
21. What staging surgery should be performed on patients with uterine papillary serous carcinoma?
Geisler JP; Geisler HE; Melton ME; Wiemann MC
Gynecol Oncol; 1999 Sep; 74(3):465-7. PubMed ID: 10479511
[TBL] [Abstract][Full Text] [Related]
22. [Construction and utilization of the prognostic model of serous ovarian adenocarcinoma].
Yang R; Feng J; Fang XZ; Bai F; Cheng YX; Liu C; Zhu W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):459-63. PubMed ID: 17083811
[TBL] [Abstract][Full Text] [Related]
23. The prognostic significance of thrombocytosis in epithelial ovarian carcinoma.
Li AJ; Madden AC; Cass I; Leuchter RS; Lagasse LD; Karlan BY
Gynecol Oncol; 2004 Jan; 92(1):211-4. PubMed ID: 14751160
[TBL] [Abstract][Full Text] [Related]
24. Thrombocytosis in women with vulvar carcinoma.
Lavie O; Comerci G; Daras V; Bolger BS; Lopes A; Monaghan JM
Gynecol Oncol; 1999 Jan; 72(1):82-6. PubMed ID: 9889035
[TBL] [Abstract][Full Text] [Related]
25. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS
Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
[TBL] [Abstract][Full Text] [Related]
26. The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer.
Rodriguez GC; Clarke-Pearson DL; Soper JT; Berchuck A; Synan I; Dodge RK
Obstet Gynecol; 1994 Mar; 83(3):445-8. PubMed ID: 8127540
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of Her-2/neu overexpression in uterine serous carcinoma.
Díaz-Montes TP; Ji H; Smith Sehdev AE; Zahurak ML; Kurman RJ; Armstrong DK; Bristow RE
Gynecol Oncol; 2006 Jan; 100(1):139-44. PubMed ID: 16182348
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of platelet count in patients with renal cell carcinoma.
Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
[TBL] [Abstract][Full Text] [Related]
29. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
[TBL] [Abstract][Full Text] [Related]
30. Uterine papillary serous carcinoma: epidemiology, pathogenesis and management.
Fader AN; Boruta D; Olawaiye AB; Gehrig PA
Curr Opin Obstet Gynecol; 2010 Feb; 22(1):21-9. PubMed ID: 19952744
[TBL] [Abstract][Full Text] [Related]
31. Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma.
Liu JF; Hirsch MS; Lee H; Matulonis UA
Gynecol Oncol; 2009 Dec; 115(3):401-6. PubMed ID: 19796795
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.
Santin AD; Diamandis EP; Bellone S; Marizzoni M; Bandiera E; Palmieri M; Papasakelariou C; Katsaros D; Burnett A; Pecorelli S
Am J Obstet Gynecol; 2006 May; 194(5):1296-302. PubMed ID: 16647913
[TBL] [Abstract][Full Text] [Related]
33. Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer.
Bozkurt N; Yuce K; Basaran M; Kose F; Ayhan A
Obstet Gynecol; 2004 Jan; 103(1):82-5. PubMed ID: 14704249
[TBL] [Abstract][Full Text] [Related]
34. Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients.
Feng Z; Wen H; Bi R; Duan Y; Yang W; Wu X
BMC Cancer; 2016 Jan; 16():43. PubMed ID: 26817451
[TBL] [Abstract][Full Text] [Related]
35. [Clinical and pathologic analysis of 33 cases of uterine papillary serous carcinoma].
Ren YL; Wang HY; Shen L; Yang WT
Zhonghua Fu Chan Ke Za Zhi; 2006 Dec; 41(12):817-21. PubMed ID: 17327111
[TBL] [Abstract][Full Text] [Related]
36. Association of pretreatment thrombocytosis with disease progression and survival in oral squamous cell carcinoma.
Lu CC; Chang KW; Chou FC; Cheng CY; Liu CJ
Oral Oncol; 2007 Mar; 43(3):283-8. PubMed ID: 16920387
[TBL] [Abstract][Full Text] [Related]
37. [Expression and clinical significance of uPA and PAI-1 in epithelial ovarian cancer].
Cai Z; Li YF; Liu FY; Feng YL; Hou JH; Zhao MQ
Ai Zheng; 2007 Mar; 26(3):312-7. PubMed ID: 17355798
[TBL] [Abstract][Full Text] [Related]
38. Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma.
Shimada H; Oohira G; Okazumi S; Matsubara H; Nabeya Y; Hayashi H; Takeda A; Gunji Y; Ochiai T
J Am Coll Surg; 2004 May; 198(5):737-41. PubMed ID: 15110807
[TBL] [Abstract][Full Text] [Related]
39. Prior breast cancer and tamoxifen exposure does not influence outcomes in women with uterine papillary serous carcinoma.
Pierce SR; Stine JE; Gehrig PA; Havrilesky LJ; Secord AA; Nakayama J; Snavely AC; Moore DT; Kim KH
Gynecol Oncol; 2017 Mar; 144(3):531-535. PubMed ID: 28062116
[TBL] [Abstract][Full Text] [Related]
40. [The prognostic value of thrombocytosis in patients with primary lung cancer].
Pedersen LM; Milman N
Ugeskr Laeger; 1998 Jun; 160(26):3917-20. PubMed ID: 9656833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
